Österreichische Kardiologische Gesellschaft 

Archive

Events

2010

• Prevention of atherosclerosis, Hospital Hochzirl, January 2010
• What does medication contribute to primary prevention?
  ASC Annual Meeting, Salzburg, June 2010
• Cardiovascular Risk Assessment
  How To Do, Salzburg, ASIM 2010

2008-2009

• Austrian activities to promote the prevention of adipositas and atherosclerosis; project presentation at the annual meeting of the AAS, Seggau, October 2008
• Prevention with 0-3-5-140-5-3-0. Can this magic formula be reached in practice?
  Events in cooperation with the Institute for Preventive and Social Medicine (IVS) of the Upper Austrian Chamber of Physicians, Linz, Nov. 2008

• Prevention of atherosclerosis. Hospital Hochzirl, Feb. 2009

• Treating healthy individuals in cardiology. ASC Annual Meeting, Salzburg, June 2009

2007

• May/June 2007, ASC Conference, Session on Prevention
• December 2007, “What are the benefits of lifestyle modifications in cardiology?” - Society of Physicians, Vienna

Research projects

• The correlations of adipocytokines with the manifestation of diabetes mellitus type 2 in patients with a metabolic syndrome

• Eating healthy at Viennese schools. Smart snack - cool break. A project to prevent adipositas and atherosclerosis. (SIPCAN in cooperation with the WG on Prevention and Atherosclerosis)
  Lecture at the Annual Meeting of the Austrian Adipositas Society (AAS) 2009, lecture at the Science Congress of the German Association for Nutrition 2010, lecture and abstract prize from the AAS 2010)
  
  
• Bread rolls with heart benefits in Viennese schools A project in the scope of the FGÖ (Foundation for a Healthy Austria) campaign “My heart and I. Healthy together.”

Publications:

VAN Eden W, Wick G, Albani S, Cohen I.: Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Ann N Y Acad Sci. 2007 Nov;1113:217-37. Epub 2007 Jun 21

Perschinka H, Wellenzohn B, Parson W, van der Zee R, Willeit J, Kiechl S, Wick G.: Identification of atherosclerosis-associated conformational heat shock protein 60 epitopes by phage display and structural alignment. Atherosclerosis 2007 Sep;194(1):79-87. Epub 2006 Nov 13.

Sourij H, Strunk D, Rohde E, Wascher TC. Association of circulating endothelial progenitor cell growth in patients with Type 2 diabetes with type of glucose-lowering treatment. Diabet Med. 2007 Aug;24(8):926-7.

Osranek M, Seward JB, Buschenreithner B, Bergler-Klein J, Heger M, Klaar U, Binder T, Maurer G, Zehetgruber M. Diastolic function assessment in clinical practice: the value of 2-dimensional echocardiography. Am Heart J. 2007 Jul;154(1):130-6.

Bernhard D, Moser C, Backovic A, Wick G. Cigarette smoke -an aging accelerator? Exp Gerontol. 2007 Mar;42(3):160-5. Epub 2006 Nov 3.

Dorner T, Fodor JG, Lawrence K, Ludvik B, Rieder A. HDL knowledge in the lay public: results of a representative population survey. Atherosclerosis. 2007 Nov;195(1):195-8. Epub 2006 Oct 27.

Wick G.: The heat is on: heat-shock proteins and atherosclerosis. Circulation 2006 Aug 29;114(9):870-2.

Saely CH, Koch L, Schmid F, Marte T, Aczel S, Langer P, Hoefle G, Drexel H. Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients. Eur J Clin Invest 2006 Feb;36(2):91-7.

Scientific Highlights 2007:

Prospective Studies Collaboration Group: Blood cholesterol and vascular mortality by age, sex and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007; 370: 1829-39.

Wang X. et al.: Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007; 369: 1876-82.

Home P.D. et al. for the RECORD Study Group: Rosiglitazone evaluated for cardiovascular outcomes – an interim analysis. N Engl J Med 2007; 357: 28-38.

Yokoyama M. et al. for the Japan EPA Lipid Intervention Study (JELIS) Investigators: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369: 1090-98.

Brouilette S.W. et al. for the West of Scotland Coronary Prevention Study Group: Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007; 369: 107-14.